BBHC
ADMA icon

Brown Brothers Harriman & Co’s ADMA Biologics ADMA Stock Holding History

Brown Brothers Harriman & Co’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-39,973
Closed -$360K – 1819
2026
Q1 		$360K Buy
39,973
+39,897
+52,496% +$630K ﹤0.01% 697
2025
Q4 		$1.39K Hold
76
– – ﹤0.01% 1767
2025
Q3 		$1.11K Hold
76
– – ﹤0.01% 1620
2025
Q2 		$1.38K Buy
+76
New +$1.55K ﹤0.01% 1469

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Brown Brothers Harriman & Co's ADMA Position: Q2 2026 in Review

Brown Brothers Harriman & Co sold out of ADMA Biologics (ADMA) in Q2 2026, closing a stake of 39,973 shares — an estimated $360K sold.

Brown Brothers Harriman & Co first reported a position in ADMA in Q2 2025 and held it in 4 quarters. The position peaked at $360K in Q1 2026. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Brown Brothers Harriman & Co reported no remaining ADMA Biologics position as of Q2 2026 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 39,973 ADMA Biologics shares in Q2 2026, an estimated $360K.
  • Brown Brothers Harriman & Co first reported a position in ADMA Biologics in Q2 2025 and held it in 4 quarters.
  • Brown Brothers Harriman & Co's ADMA Biologics position peaked at $360K in Q1 2026.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.